Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead faces challenge to European patent on pricey hep C drug
Yahoo/Reuters
Tue, 02/10/15 - 10:21 am
Gilead Sciences
Europe
patents
hepatitis C
Sovaldi
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Achillion
hepatitis C
ACH-3102
Gilead Sciences
Sovaldi
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade
Barron's
Sat, 02/7/15 - 10:23 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
Gilead's Harvoni Selected as Cigna Preferred Treatment for Hepatitis C Genotype 1
NASDAQ.com
Fri, 02/6/15 - 10:25 am
Gilead Sciences
Harvoni
Cigna
hepatitis C
[video]3 Things You Ought to Know About Gilead's Tumble
Motley Fool
Fri, 02/6/15 - 09:06 am
Gilead Sciences
Bigger drug discounts put question mark over Gilead's stellar run
Fortune
Wed, 02/4/15 - 10:18 am
Gilead Sciences
drug discounts
hepatitis C
Sovaldi
Harvoni
Gilead Profit Soars But HCV Drug Rival Weighs On Outlook
Yahoo/Investors Business Daily
Wed, 02/4/15 - 08:24 am
Gilead Sciences
earnings
Gilead Sciences is ‘Very Conservative When It Comes to Guidance!’
Barron's
Mon, 02/2/15 - 05:46 pm
Gilead Sciences
Can The Biotech Sector See Stellar Results For 2015 Amid Price Wars?
Bidness Etc.
Mon, 02/2/15 - 09:57 am
drug pricing
biotech
Gilead Sciences
AbbVie
3 Things to Watch with Gilead Sciences, Inc. Q4 Results
Motley Fool
Mon, 02/2/15 - 07:50 am
Gilead Sciences
earnings
In cystic fibrosis drug launch prep, Vertex learns from Sovaldi mistakes
Bizjournals.com
Sat, 01/31/15 - 09:58 am
cystic fibrosis
Vertex Pharmaceuticals
Sovaldi
drug launches
Gilead Sciences
lumacaftor
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
hepatitis C
Viekira Pak
Gilead Sciences, Inc. Harvoni Gets Preferred Status From UnitedHealth Group (UNH)
Bidness Etc.
Thu, 01/29/15 - 11:11 am
Gilead Sciences
hepatitis C
United Health
Harvoni
AbbVie
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Viekira Pak
Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment
WSJ Online
Mon, 01/26/15 - 07:52 am
generics
Gilead Sciences
hepatitis C
Sovaldi
India
Patients Blame Cost for Coverage Delay in England of Gilead Drug
WSJ Pharmalot
Fri, 01/23/15 - 08:21 am
UK
Gilead Sciences
patients
Sovaldi
hepatitis C
Gilead’s John Martin Named Morningstar CEO of 2014
Barron's
Wed, 01/21/15 - 06:00 pm
John Martin
Gilead Sciences
Pharma CEOs
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
Can Gilead Sciences Beat Hep-C Estimates?
Barron's
Tue, 01/20/15 - 03:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Pages
« first
‹ previous
…
64
65
66
67
68
69
70
71
72
…
next ›
last »